A detailed history of First Trust Advisors LP transactions in Morphic Holding, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 26,867 shares of MORF stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,867
Holding current value
$1.53 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$26.12 - $34.07 $701,766 - $915,358
26,867 New
26,867 $915,000
Q3 2023

Nov 13, 2023

BUY
$21.33 - $59.42 $32,954 - $91,803
1,545 Added 1.67%
93,918 $2.15 Million
Q2 2023

Aug 14, 2023

BUY
$34.33 - $62.11 $3.17 Million - $5.74 Million
92,373 New
92,373 $5.3 Million
Q2 2022

Aug 12, 2022

SELL
$19.74 - $43.01 $597,312 - $1.3 Million
-30,259 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$36.25 - $52.02 $620,890 - $890,998
-17,128 Reduced 36.14%
30,259 $1.22 Million
Q4 2021

Feb 08, 2022

BUY
$43.27 - $65.72 $2.05 Million - $3.11 Million
47,387 New
47,387 $2.25 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.